Javier Garcia, MBA
Javier García is a Founding Partner at Columbus Venture Partners. He spent 25 years at Eli Lilly and Company, where he held various executive positions in Business Development and Information…
Emma Bonser
Emma Bonser is the Chief Executive Officer of Genetic Alliance Australia, a national peak body representing people and families affected by less common, rare and undiagnosed genetic conditions. She brings…
Prof. Federico Mingozzi, PhD
The Chief Executive Officer of Nava Therapeutics. Former Chief Science & Technology Officer at Spark Therapeutics and Research Group Leader at INSERM and Genethon in France. He serves on the…
Prof. Gloria González Aseguinolaza, PhD
University of Navarra - Spain
The Director of the Gene Therapy for Rare Diseases Program at CIMA Universidad de Navarra, co-founder and former CSO of Vivet Therapeutic. She is a globally recognised for her expertise…
Joy A. Cavagnaro, PhD, DABT, ATS, RAC
Former Senior Biomedical Research Service Scientist at CBER/FDA and FDA safety topic lead and rapporteur for ICH S6. International expert in preclinical development and translational safety evaluation of biopharmaceuticals. She…